174 related articles for article (PubMed ID: 6446878)
1. Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.
Meyers BR; Hirschman SZ; Strougo L; Srulevitch E
Antimicrob Agents Chemother; 1980 Apr; 17(4):608-11. PubMed ID: 6446878
[TBL] [Abstract][Full Text] [Related]
2. Ticarcillin vs carbenicillin: clinical pharmacokinetics.
Libke RD; Clarke JT; Ralph ED; Luthy RP; Kirby WM
Clin Pharmacol Ther; 1975 Apr; 17(4):441-6. PubMed ID: 1122685
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin kinetics.
Batra VK; Morrison JA; Lasseter KC; Joy VA
Clin Pharmacol Ther; 1979 Jul; 26(1):41-53. PubMed ID: 445961
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.
Neu HC; Garvey GJ
Antimicrob Agents Chemother; 1975 Oct; 8(4):457-62. PubMed ID: 1190752
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ticarcillin in man.
Davies BE; Humphrey MJ; Langley PF; Lees L; Legg B; Wadds GA
Eur J Clin Pharmacol; 1982; 23(2):167-72. PubMed ID: 7140806
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of carbenicillin, carfecillin, ticarcillin and BL-P 1654 in dairy cows.
Nouws JF; Ziv G; Van Ginneken CA; Vree TB
J Vet Pharmacol Ther; 1984 Mar; 7(1):35-43. PubMed ID: 6323731
[TBL] [Abstract][Full Text] [Related]
7. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
Russo J; Russo ME
Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
Monif GR; Clark PR; Shuster JJ; Baer H
Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin.
Viollier AF; Standiford HC; Drusano GL; Tatem BA; Moody MR; Schimpff SC
J Antimicrob Chemother; 1985 May; 15(5):597-606. PubMed ID: 4008387
[TBL] [Abstract][Full Text] [Related]
10. The tissue penetration, as measured by a blister technique, and pharmacokinetics of cefsulodin compared with carbenicillin and ticarcillin.
Findlay CD; Wise R; Allcock JE; Durham SR
J Antimicrob Chemother; 1981 Jun; 7(6):637-42. PubMed ID: 7251531
[No Abstract] [Full Text] [Related]
11. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
Shah PP; Briedis DJ; Robson HG; Conterato JP
Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of low- and high-dose ticarcillin.
Guglielmo BJ; Flaherty JF; Batman R; Barriere SL; Gambertoglio JG
Antimicrob Agents Chemother; 1986 Sep; 30(3):359-60. PubMed ID: 3777901
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
Sobel JD; Levison ME; Kaye D
Infection; 1980; 8(3):121-2. PubMed ID: 6448229
[TBL] [Abstract][Full Text] [Related]
14. Ticarcillin: pharmacokinetics in man according to different administration schedules.
Dalhoff A; Höffler D
J Int Med Res; 1977; 5(5):308-21. PubMed ID: 913858
[TBL] [Abstract][Full Text] [Related]
15. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.
Thompson MI; Russo ME; Saxon BJ; Atkin-Thor E; Matsen JM
Antimicrob Agents Chemother; 1982 Feb; 21(2):268-73. PubMed ID: 6462107
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis].
de Meirleire F; Fauchere JL; Simon G
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381
[TBL] [Abstract][Full Text] [Related]
18. Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1980 Nov; 20(5):325-52. PubMed ID: 7002527
[TBL] [Abstract][Full Text] [Related]
19. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
Gwynn MN; Rolinson GN
Infection; 1980; 8(2):73-80. PubMed ID: 6771215
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of ticarcillin, clavulanic acid and their combination.
Höffken G; Tetzel H; Koeppe P; Lode H
J Antimicrob Chemother; 1986 May; 17 Suppl C():47-55. PubMed ID: 3722046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
